DongKook Pharmaceutical Valuation
| 086450 Stock | KRW 16,590 240.00 1.47% |
At this time, the firm appears to be overvalued. DongKook Pharmaceutical shows a prevailing Real Value of W14164.5 per share. The current price of the firm is W16590.0. Our model computes the value of DongKook Pharmaceutical from reviewing the firm fundamentals such as Shares Outstanding of 8.79 M, current valuation of 1.08 T, and Profit Margin of 0.07 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that DongKook Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of DongKook Pharmaceutical is based on 3 months time horizon. Increasing DongKook Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since DongKook Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DongKook Stock. However, DongKook Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16590.0 | Real 14164.5 | Hype 16590.0 | Naive 16602.24 |
The real value of DongKook Stock, also known as its intrinsic value, is the underlying worth of DongKook Pharmaceutical Company, which is reflected in its stock price. It is based on DongKook Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of DongKook Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of DongKook Pharmaceutical Co helps investors to forecast how DongKook stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DongKook Pharmaceutical more accurately as focusing exclusively on DongKook Pharmaceutical's fundamentals will not take into account other important factors: DongKook Pharmaceutical Total Value Analysis
DongKook Pharmaceutical Co is presently forecasted to have takeover price of 1.08 T with market capitalization of 145.91 B, debt of 13.69 B, and cash on hands of 85.44 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the DongKook Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.08 T | 145.91 B | 13.69 B | 85.44 B |
DongKook Pharmaceutical Investor Information
About 47.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. DongKook Pharmaceutical had 5:1 split on the 10th of September 2020. DongKook Pharmaceutical Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.DongKook Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DongKook Pharmaceutical has an asset utilization ratio of 79.22 percent. This suggests that the Company is making W0.79 for each dollar of assets. An increasing asset utilization means that DongKook Pharmaceutical Co is more efficient with each dollar of assets it utilizes for everyday operations.DongKook Pharmaceutical Ownership Allocation
The market capitalization of DongKook Pharmaceutical is W145.91 Billion. DongKook Pharmaceutical Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.DongKook Pharmaceutical Profitability Analysis
The company reported the revenue of 594.19 B. Net Income was 52.92 B with profit before overhead, payroll, taxes, and interest of 337.12 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates DongKook Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in DongKook Pharmaceutical and how it compares across the competition.
About DongKook Pharmaceutical Valuation
The stock valuation mechanism determines DongKook Pharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of DongKook Pharmaceutical. We calculate exposure to DongKook Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DongKook Pharmaceutical's related companies.DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea. DongKook Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct DongKook Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DongKook Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DongKook Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain DongKook Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine DongKook Pharmaceutical's revenue streams: Identify DongKook Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research DongKook Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish DongKook Pharmaceutical's growth potential: Evaluate DongKook Pharmaceutical's management, business model, and growth potential.
- Determine DongKook Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DongKook Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for DongKook Stock analysis
When running DongKook Pharmaceutical's price analysis, check to measure DongKook Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DongKook Pharmaceutical is operating at the current time. Most of DongKook Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of DongKook Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DongKook Pharmaceutical's price. Additionally, you may evaluate how the addition of DongKook Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |